I'm with you on looking forward to the NIH topline data.
It's unfortunate that this wait has been so costly and unnecessary. We know that our work on using CRP as a biomarker has been accepted for publication. I personally think that peer review is just as important to us as TLD. But I'll damn sure take the release of both.